Search

everythinglearnresearchcommunity

for

Search:↓

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

New compounds may soon be tested to treat excessive hair growth in women.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.